SM
AGTC

Sabby Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Sabby Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,737
Closed -$293K – 158
2022
Q1 		$293K Buy
2,737
+2,617
+2,181% +$4.76K 0.04% 85
2021
Q4 		$23K Buy
+120
New +$287 ﹤0.01% 182
2021
Q3 		– Sell
-1,545
Closed -$604K – 214
2021
Q2 		$604K Sell
1,545
-2,230
-59% -$9.24K 0.09% 101
2021
Q1 		$1.91M Buy
+3,775
New +$19.6K 0.37% 54

Other funds holding AGTC

PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sabby Management's AGTC Position: Q3 2022 in Review

Sabby Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2022, closing a stake of 811,973 shares — an estimated $625K sold.

Sabby Management first reported a position in AGTC in Q1 2015 and held it in 5 quarters. The position peaked at $3M in Q1 2015. 45 funds tracked by Wall St. Rank hold AGTC as of Q3 2022.

  • Sabby Management reported no remaining Applied Genetic Technologies Corporation position as of Q3 2022 after selling out during the quarter.
  • Sabby Management sold 811,973 Applied Genetic Technologies Corporation shares in Q3 2022, an estimated $625K.
  • Sabby Management first reported a position in Applied Genetic Technologies Corporation in Q1 2015 and held it in 5 quarters.
  • Sabby Management's Applied Genetic Technologies Corporation position peaked at $3M in Q1 2015.
  • 45 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2022.

Based on Sabby Management's 13F filing for Q3 2022, filed 14 Nov 2022.